NIKKEI 225
38,357.53 +155.16 (+0.41%) HANG SENG
18,437.14 +123.28 (+0.67%) CRUDE OIL
79.28 +0.29 (+0.37%) GOLD FUTURES
2,315.40 -6.90 (-0.30%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,229.21 -943.11 (-1.88%)
Catalyst Pharmaceuticals, Inc. (CPRX)
After hours:
| Previous close | 15.14 |
| Open | 15.20 |
| Bid | 14.68 x 100 |
| Ask | 14.73 x 300 |
| Day's range | 14.53 - 15.22 |
| 52-week range | 11.09 - 17.51 |
| Volume | |
| Avg. volume | 1,325,957 |
| Market cap | 1.737B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 23.37 |
| EPS (TTM) | 0.63 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.71 |
GlobeNewswireCatalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
Achieved Total Q1 2024 Revenues of $98.5 Million, a 15.4% YoY Increase, Underscored by Exceptional Execution and Continued Demand for Commercial Products FIRDAPSE® Q1 2024 Net Product Revenues of $66.8 Million, a 16.2% YoY Increase Robust Revenue Momentum for FIRDAPSE® Successfully Commenced the U.S. Launch of AGAMREE® on March 13, 2024 Reported AGAMREE® Q1 2024 Net Product Revenues of $1.2 Million for the First Two Weeks of Commercial Availability Early AGAMREE® Launch Indicators Highlight Prom
ZacksCollegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ZacksCatalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
Catalyst (CPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
